Aggressive antiplatelet therapy before coronary stent implantation in acute coronary syndrome with essential thrombocythemia: A case report

Angiology

Volumn 54, Issue 4, 2003, Pages 485-490

  Fujimura, Mitsunori ^a   Akaike, Masashi ^a   Kato, Midori ^a   Takamori, Nobuyuki ^a   Abe, Masahiro ^a   Nishiuchi, Takeshi ^b   Azuma, Hiroyuki ^a   Matsumoto, Toshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Kawashima Cardiovascular Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA THROMBOGLOBULIN; DILTIAZEM; HEPARIN; HYDROXYUREA; THROMBOCYTE FACTOR 4; TICLOPIDINE;

ADULT; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BONE MARROW BIOPSY; CASE REPORT; CELL ASSAY; CONTINUOUS INFUSION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DISEASE ASSOCIATION; FOLLOW UP; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MEGAKARYOCYTE; OUTCOMES RESEARCH; PROGNOSIS; PROTEIN BLOOD LEVEL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 0043168033     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970305400414     Document Type: Article

References (19)

1. Rossi C, Randi L, Zerbinati P, et al: Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med 244:49-53, 1998.
2. Turgut T, Harjai KJ, Edupuganti R, et al: Acute coronary occlusion and in-stent thrombosis in a patient with essential thrombocythemia. Cathet Cardiovasc Diagn 45:428-433, 1998.
3. Cortelazzo S, Viero P, Finazzi G, et al: Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 8:556-562, 1990.
4. Hanger KH, Kilgore J, James E: Essential thrombocythemia and coronary artery disease. Chest 86:933-935, 1984.
5. Douste-Blazy P, Taudou MJ, Delay M, et al: Essential thrombocythemia and recurrent myocardial infarction [letter]. Lancet 27:992, 1984.
6. Yano K, Takeyama H, Watanabe E, et al: A case of essential thrombocythemia associated with myocardial and cerebral infarction. Naika 57:177-179, 1986.
7. Louwerenburg JW, Suttorp MJ, Kingma JH: Aspirin withdrawal in a patient with essential thrombocythemia: possible cause of myocardial infarction [letter]. Am J Med 83:1175, 1987.
8. Ushiyama K, Aoki Y, Ninomiya H, et al: A case of essential thrombocythemia with acute myocardial infarction. Naika 60:1399-1402, 1987.
9. Suzuki A, Suzuki F, Takahata H, et al: Essential thrombocythemia associated with myocardial infarction - a case report. Shinzo 20:444-450, 1988.
10. Hamada Y, Matsuda Y, Fujii B, et al: Multiple coronary thrombosis in a patient with thrombocytosis. Clin Cardiol 12:723-724, 1989.
11. Furui J, Yamada Y, Tsuzuki M, et al: A case of essential thrombocythemia associated with acute myocardial infarction. Shinzo 22:180-184, 1990.
12. Scheffer MG, Michiels JJ, Simoons ML, et al: Thrombocythemia and coronary artery disease. Am Heart J 122:573-576, 1991.
13. Momiyama T, Hiranaka T, Nomura F, et al: Coronary artery bypass grafting for left main trunk coronary artery lesion associated with essential thrombocythemia. Clin Cardiol 16:691-693, 1993.
14. Nakatani H, Sakaguchi Y, Nishida I, et al: A case of acute myocardial infarction associated with essential thrombocythemia: Platelet function in a patient with essential thrombocythemia. Shinzo 30:567-572, 1998.
15. Michaels AD, Whisenant B, Macgregor JS: Multivessel coronary thrombosis treated with Abciximab (ReoPro®) in a patient with essential thrombocythemia. Clin Cardiol 21:134-138, 1998.
16. Esteves A, Costa FA, Guimaraes AA, et al: Essential thrombocythemia and acute myocardial infarction treated with rescue coronary angioplasty. Arq Bras Cardiol 73:100-102, 1999.
17. Senno SL, Pechet L: Clinical implications of elevated PAI-1 revisited: Multiple arterial thromboses in a patient with essential thrombocythemia and elevated plasminogen activator inhibitor-1(PAI-1) level: A case report and review of the literature. J Thromb Thrombolysis 8:105-112, 1999.
18. Fuster V, Bandimon L, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326:242-250, 1992.
19. Bellucci S, Lgnatova E, Jaillet N, et al: Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damages as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA, and vWF. Thromb Haemost 70:736-742, 1993.